compar studi ticarcillin plu tobramycin versu carbenicillin plu gentamicin treatment seriou infect due gramneg bacilli combin ticarcillin plu tobramycin tt carbenicillin plu gentamicin cg use treat 82 patient sever system gramneg infect prospect random studi pseudomona aeruginosa primari pathogen 7 93 per cent patient patient treat tt respond frequent 92 per cent 37 40 patient treat cg 71 per cent 30 42 p less 005 differ primarili due greater respons tt patient pulmonari infect 93 per cent versu 68 per cent infect due pseudomona 92 per cent versu 70 per cent sever underli diseas also import determin respons except greater incid hepatotox cg 23 per cent versu 3 per cent p less 002 differ toxic colon drugresist microorgan superinfect two treatment group combin tt appear superior cg treatment pulmonari infect due pseudomona aeruginosa